Synthetic gene cluster and synthetic method of sorbic acid

By using heterologous expression of polyphenol synthase gene saA and hydrolase gene saB in Aspergillus nitritis, the problem of silencing state of unresolved gene clusters in the microbial genome is solved, the biosynthesis of sorbic acid is achieved, and sorbic acid is provided. The green manufacturing approach solves the problem that sorbic acid is difficult to synthesize in the prior art.

CN118956801APending Publication Date: 2024-11-15FUJIAN NORMAL UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411070679.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art is difficult to effectively utilize unresolved secondary metabolites biosynthetic gene clusters in the microbial genome, making it difficult to achieve the synthesis of sorbic acid.

Method used

Provide a biosynthetic gene cluster containing the polyphenyl synthase gene saA and the hydrolase gene saB. The biosynthetic gene of sorbic acid is achieved through heterologous expression in Aspergillus nitritis. These genes are introduced into the host microorganism using recombinant vectors and recombinant microbial technology. Use specific promoters to drive gene expression to achieve sorbic acid synthesis.

Benefits of technology

The green biomanufacturing of sorbic acid has been successfully achieved, providing new biosynthesis pathways, and providing innovative methods for the production of sorbic acid, which is of reference significance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention discloses a synthetic gene cluster and a synthetic method of sorbic acid. The invention provides any one of the following substances: A1) polyketide synthase; a2) a biological material related to the polyketide synthase shown in A1); a3) hydrolase; a4) a biological material related to the hydrolase shown in A3); a5) a combination of A1) and A3), and A6) a combination of A2) and A4), a new sorbic acid biosynthetic gene cluster is found and is not reported in currently disclosed literatures, the biosynthetic gene cluster containing a polyketide synthase gene saA and a hydrolase gene saB is used for heterologous expression to synthesize sorbic acid for the first time, and the method has reference significance for green biological manufacturing of sorbic acid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of gene engineering, and in particular relates to a synthetic gene cluster and a synthetic method of sorbic acid. Background Art

[0002] Sorbic acid, a natural preservative, was first extracted from ash berries in 1859. As an unsaturated fatty acid, sorbic acid has two carbon-carbon double bonds, both in trans configuration. Studies have shown that sorbic acid has significant antimicrobial activity, and it is noteworthy that its antimicrobial activity increases with decreasing pH of the culture medium. In a low pH environment, the acid is completely protonated and is thus more easily absorbed by microorganisms. Therefore, sorbic acid is widely used in the processing of cheese, wine, juice and some baked goods to inhibit the growth of yeast and mold. In addition, sorbic acid is also seen as a substitute for nitrite preservation and is used in meat processing.

[0003] With the continuous maturity of genome sequencing technology and the publication of many microbial genome sequences, there are a large number of unresolved secondary metabolite biosynthetic gene clusters in microbial genomes. The synthesis of microbial secondary metabolites is strictly regulated, and most gene clusters are silent under laboratory culture conditions. By using methods such as heterologous expression, mining these gene clusters and forcibly activating the "silent" genes in the gene clusters, combined with traditional separation methods, it has become an important way to develop new natural products. Summary of the invention

[0004] The technical problem solved by the invention is to provide a sorbic acid synthesis gene cluster and application thereof.

[0005] In order to solve the above technical problems, the first aspect of the present invention provides any of the following substances: A1) Polyketide synthase; A2) biological materials related to the polyketide synthase shown in A1); A3) Hydrolases; A4) biological materials related to the hydrolases shown in A3); A5) A combination of A1) and A3); A6) A combination of A2) and A4); The polyketide synthase is any one of the following: B1) comprising the protein shown in SEQ ID NO: 3; B2) a protein that has 95% or more identity to SEQ ID NO: 3 and has the same biological function; The hydrolase is any one of the following: B3) comprising the protein shown in SEQ ID NO: 4; B4) A protein that has 95% or more identity with SEQ ID NO: 4 and has the same biological function.

[0006] The above protein having 95% or more identity with SEQ ID NO: 3 and having the same biological function specifically refers to a protein having 95% or 96% or 97% or 98% or 97% identity with SEQ ID NO: 3 and having the same biological function.

[0007] The above-mentioned protein having 95% or more identity with SEQ ID NO: 4 and having the same biological function specifically refers to a protein having 95% or 96% or 97% or 98% or 97% identity with SEQ ID NO: 4 and having the same biological function.

[0008] Among the substances described above, the biological material related to the polyketide synthase shown in A1) is any one of the following: C1) a nucleic acid molecule encoding the polyketide synthase; C2) an expression cassette containing the nucleic acid molecule described in C1); C3) a recombinant vector containing the nucleic acid molecule described in C1); C4) a recombinant vector containing the expression cassette described in C2); C5) a recombinant microorganism containing the nucleic acid molecule described in C1); C6) a recombinant microorganism containing the expression cassette described in C2); C7) a recombinant microorganism containing the recombinant vector described in C3); C8) a recombinant microorganism containing the recombinant vector described in C4); Or, the biological material related to the hydrolase shown in A3) is any one of the following: D1) a nucleic acid molecule encoding the hydrolase; D2) an expression cassette containing the nucleic acid molecule described in D1); D3) a recombinant vector containing the nucleic acid molecule described in D1); D4) a recombinant vector containing the expression cassette described in D2); D5) a recombinant microorganism containing the nucleic acid molecule described in D1); D6) a recombinant microorganism containing the expression cassette described in D2); D7) a recombinant microorganism containing the recombinant vector described in D3); D8) A recombinant microorganism containing the recombinant vector described in D4).

[0009] In the above, the nucleic acid molecule encoding polyketide synthase is any one of the following: C1-1) a DNA molecule whose coding sequence comprises SEQ ID No. 1; C1-2) a cDNA molecule or a DNA molecule that hybridizes with the DNA molecule defined in C1-1) and encodes a protein having the same function; Or, the nucleic acid molecule encoding the hydrolase is any one of the following: D1-1) a DNA molecule whose coding sequence comprises SEQ ID No. 2; D1-2) A cDNA molecule or a DNA molecule that hybridizes with the DNA molecule defined in D1-1) and encodes a protein having the same function.

[0010] Among the substances mentioned above, The combination of A1) and A3) can be a combination of polyketide synthase and hydrolase, or a fusion protein composed of polyketide synthase and hydrolase; The combination of A2) and A4) can be a combination of a nucleic acid molecule encoding the polyketide synthase and a nucleic acid molecule encoding the hydrolase, or a fusion gene composed of individual nucleic acids, or a combination of a recombinant vector expressing a nucleic acid molecule encoding a polyketide synthase and a recombinant vector expressing a nucleic acid molecule encoding a hydrolase, or a recombinant microorganism expressing a nucleic acid molecule encoding a polyketide synthase and a nucleic acid molecule encoding a hydrolase.

[0011] In a second aspect, the present invention provides a recombinant microorganism, which contains the gene encoding the polyketide synthase and the gene encoding the hydrolase in the first aspect, and expresses the polyketide synthase and the hydrolase.

[0012] In the above-mentioned recombinant microorganism, the recombinant microorganism is a fungus or a bacterium; And / or, the fungus is Aspergillus nidulans.

[0013] In a third aspect, the present invention provides a method for constructing the recombinant microorganism described in the second aspect, comprising the following steps: introducing the coding gene of the polyketide synthase and the coding gene of the hydrolase in the first aspect into a host microorganism to obtain a recombinant microorganism.

[0014] In the above method, the host microorganism is a fungus or a bacterium; And / or, the fungus is Aspergillus nidulans.

[0015] In the embodiment of the present invention, the recombinant vector pJB118, the recombinant vector pJB119 and the blank pYTR are co-transformed into Aspergillus nidulans A. nidulans A1145 obtained recombinant bacteria.

[0016] The recombinant vector pJB118 can be used to transfer the polyketide synthase gene AHReplace the fragment between the SwaI restriction sites of the pYTU vector to obtain a vector containing the polyketide synthase gene AH Located in the carrier Gla Downstream of the promoter (GenBank: EF428455.1), Gla Promoter-driven polyketide synthase gene AH Express.

[0017] The recombinant vector pJB119 can be used to transfer the hydrolase gene B Replace the fragment between the SwaI restriction sites of the pYTP vector to obtain a vector containing the hydrolase gene B Located in the carrier AmyB Downstream of the promoter (GenBank: CP031434.1), AmyB Promoter driven hydrolase gene B Express.

[0018] In a fourth aspect, the present invention provides a recombinant microorganism prepared by the method described in the third aspect.

[0019] In a fifth aspect, the present invention provides the use of the substance described in the first aspect in any of the following: E1) preparing a recombinant microorganism for synthesizing sorbic acid; E2) Synthesize sorbic acid.

[0020] In a sixth aspect, the present invention provides use of the recombinant microorganism described in the first aspect or the second aspect in synthesizing sorbic acid.

[0021] In a seventh aspect, the present invention provides a method for synthesizing sorbic acid, comprising the following steps: fermenting the recombinant microorganism described in the first aspect or the second aspect to obtain sorbic acid.

[0022] The above fermentation comprises the following steps: 1) Seed culture medium: The recombinant microorganism was inoculated into the seed culture medium and cultured at 37°C for 3 days until the strain produced spores; 2) Fermentation The spores obtained in 1) above were then spread on a fermentation medium and cultured at 30°C for 3 days to obtain a fermentation product.

[0023] The seed culture medium is CD culture medium, including 1% Glucose, 2% Agar, 5% 20x Nitrate salts (V / V) and 0.1% Trace elements (V / V) by mass fraction, and the balance is water; The fermentation medium is CD-ST medium, including 2% Starch, 2% Agar, 2% Tryptone, 5% 20x Nitrate salts (V / V) and 0.1% Trace elements (V / V) in mass fractions, and the balance is water.

[0024] The above 20x Nitrate contains 120 g / L NaNO3, 10.4 g / L KCl, 10.4 g / L MgSO4•7H2O and 30.4 g / L KH2PO4, with the balance being water; the above Trace elements contain 22.0 g / L ZnSO4•7H2O, 11.0 g / L H3BO3, 5.0 g / L MnCl2•4H2O, 1.6 g / L FeSO4•7H2O, 1.6 g / L CoCl2•5H2O, 1.6 g / L CuSO4•5H2O, 1.11 g / L (NH4)6Mo7O 24 •4H2O, balance is water.

[0025] The structural formula of sorbic acid described in this article is as follows:

[0026] Formula 1 The beneficial effects of the present invention are as follows: the present invention discovered a new sorbic acid biosynthetic gene cluster, which has not been reported in the currently published literature, and is the first to utilize a polyketide synthase gene cluster to AH and hydrolase genes B The biosynthetic gene cluster is heterologously expressed to synthesize sorbic acid, which has reference significance for the green biomanufacturing of sorbic acid. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 Schematic diagram of the sorbic acid biosynthesis gene cluster.

[0028] Figure 2 Schematic representation of plasmids pJB118 and pJB119 used for the construction of sorbic acid heterologous expression strains.

[0029] Figure 3 This is the LC-MS detection diagram of the fermentation and metabolites of the heterologous expression strain.

[0030] Figures 4 to 8 The nuclear magnetic spectrum of sorbic acid synthesized by the present invention.

[0031] Fig. 9 This is the standard curve for detecting sorbic acid concentration by liquid chromatography. DETAILED DESCRIPTION

[0032] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.

[0033] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0034] Unless otherwise specified, the quantitative tests in the following examples were performed three times and the results were averaged.

[0035] In order to make the technical problem to be solved by the present invention, the technical solution and the beneficial effects more clearly understood, the present invention is further described in detail below in conjunction with the embodiments.

[0036] pYTU vector, pYTP vector and pYTR vector are all recorded in the following literature: Gao, Y#, Xie M#, Yu C, Zhang M, Huang J, Li Q, Zhang H, Li L*. Heterologous Expression of Macrollinsfrom Phytopathogenic Macrophomina phaseolina Revealed a Cytochrome P450Monooxygenase in the Biosynthesis of β-Hydroxyl Tetramic Acid, Journal of Agricultural and Food Chemistry 2021, 69(50): 15175-15183.

[0037] Example 1. Construction of recombinant bacteria AN-sa heterologously expressing sorbic acid biosynthetic gene cluster Figure 1 Schematic diagram of the sorbic acid biosynthesis gene cluster.

[0038] 1. Construction of recombinant vector 1) Recombinant vector pJB118 The recombinant vector pJB118 is used to transfer the polyketide synthase gene AH Replace the fragment between the SwaI restriction sites of the pYTU vector to obtain a vector containing the polyketide synthase gene AH Located in the carrier GlaDownstream of the promoter (GenBank: EF428455.1), Gla Promoter-driven polyketide synthase gene AH Express.

[0039] Polyketide synthase gene AH The nucleotide sequence is sequence 1, which encodes the protein polyketide synthase saA, and the amino acid sequence of the protein is sequence 3.

[0040] The specific construction method is as follows: by Myrothecium sp. The genome of FJNU 6 (CGMCC NO.41255) was used as a template and 118-A-1F / 2R as primers to amplify the complete polyketide synthase gene using PCR. AH The PCR products and the pYTU vector fragments digested with SwaI were collected and assembled into the expression plasmid pJB118 using Gibson (expression plasmid pJB118 as shown in Figure 2 as shown). 2) Recombinant vector pJB119 The recombinant vector pJB119 is used to insert the hydrolase gene B Replace the fragment between the SwaI restriction sites of the pYTP vector to obtain a vector containing the hydrolase gene B Located in the carrier AmyB Downstream of the promoter (GenBank: CP031434.1), AmyB Promoter driven hydrolase gene B Express.

[0041] Hydrolases B The nucleotide sequence of the gene is sequence 2, which encodes the proteolytic enzyme saB, and the amino acid sequence of the protein is sequence 4.

[0042] The specific construction method is as follows: by Myrothecium sp . FJNU 6 CGMCC NO.41255 genome was used as template and 119-BF / R as primer to amplify the hydrolase B Gene; Collect PCR products and pYTP vector fragments digested with SwaI, and assemble them into expression plasmid pJB119 using Gibson (expression plasmid pJB119 as Figure 2 as shown).

[0043] 2. Construction of recombinant bacteria The recombinant vector pJB118, the recombinant vector pJB119 and the blank vector pYTR were co-transformed into Aspergillus nidulans using the PEG-mediated method. Aspergillus nidulans A1145( A. nidulansA1145), the host bacteria has three nutritional deficiencies, so it is necessary to introduce the pyr (GenBank: CP084967.1), the recombinant vector pJB119 pyroA (GenBank: CP097567.1) and pYTR riboB (GenBank: BX649606.1) supplemented the missing nutrients and constructed a recombinant bacterium AN-sa that heterologously expressed the sorbic acid biosynthesis gene cluster.

[0044] The blank plasmid vectors pYTU, pYTP and pYTR were co-transformed into Aspergillus nidulans using the same method as above. A. nidulans In A1145, the control recombinant bacteria AN were constructed.

[0045] The above primer sequences are shown in Table 1.

[0046] Table 1 shows the primer sequences

[0047] 3. Expression of recombinant bacteria AN-sa The recombinant bacteria AN-sa constructed in the above 2 was inoculated into solid fermentation medium CD-ST (2% Starch (W / W), 2% Tryptone (W / W), 2% Agar (W / W), 5% 20x Nitrate salts (V / V) and 0.1% Trace elements (V / V), the balance being water), cultured at 30°C for 3 days, and the fermentation products were collected and recorded as fermentation products.

[0048] About 0.5cm 3 The fermentation product was placed in a 1.5 mL EP tube, crushed with a pipette tip, extracted with 800 µL of extraction solution (89% ethyl acetate (V / V), 10% methanol (V / V) and 1% acetic acid (V / V)), vortexed for 1 min, ultrasonicated for 10 min, and then centrifuged at 12,000 rpm for 5 min. The supernatant was concentrated under reduced pressure to remove the extract, and then 100 µL of methanol was used to dissolve the extract, recorded as the fermentation expression sample, and filtered with a 0.22 µm filter membrane for LC-MS analysis.

[0049] The analysis method is as follows: The instrument used is a Thermo U3000 HPLC-LCQ fleet mass spectrometer equipped with a phenomenexLuna 5 µm C18(2), 150 x 2.1 mm column, the liquid column temperature is controlled at 30°C, and the detection wavelength is set to 200-800 nm. The liquid chromatography flow rate is 0.25 mL / min, the mobile phase A is ultrapure water containing 0.1% formic acid, and the mobile phase B is HPLC-grade acetonitrile containing 0.1% formic acid. During 0-30 min, the B phase is linearly increased from 5% to 95%. The mass spectrometer ion source setting parameters are: nebulizer pressure is 35 psi, dry gas flow is 35 mL / min, temperature is 350°C, the scanning mode is positive and negative ion continuous full scan, and the scanning range is m / z =50-160.

[0050] The results of LC-MS are as follows Figure 3 As shown in the figure, compared with the control recombinant bacteria AN, the fermentation product of AN-sa showed a compound peak at 13.75 min, and its [M+1] ion peak was 113, proving that the polyketide synthase gene AH and hydrolase genes B The introduction of 2-nidulans bacteria added a single compound to the fermentation product of Aspergillus nidulans.

[0051] The following is an expanded culture to verify the type and composition of the added single compounds.

[0052] Example 2: Biosynthesis of Sorbic Acid 1. Fermentation of recombinant bacteria 1) Seed cultivation: The recombinant bacteria AN-sa constructed in Example 1 was inoculated into the seed culture medium and cultured at 37° C. for 3 days until the strain produced spores; 2) Fermentation The spores obtained in 1) above were then spread on a fermentation medium and cultured at 30°C for 3 days to obtain a fermentation product.

[0053] The seed culture medium is CD culture medium, including 1% Glucose, 2% Agar, 5% 20x Nitrate salts (V / V) and 0.1% Trace elements (V / V) by mass fraction, and the balance is water; The fermentation medium is CD-ST medium, including 2% Starch, 2% Agar, 2% Tryptone, 5% 20x Nitrate salts (V / V) and 0.1% Trace elements (V / V) in mass fractions, and the balance is water.

[0054] The above 20x Nitrate contains 120 g / L NaNO3, 10.4 g / L KCl, 10.4 g / L MgSO4•7H2O and 30.4 g / L KH2PO4, with the balance being water; the above Trace elements contain 22.0 g / L ZnSO4•7H2O, 11.0 g / L H3BO3, 5.0 g / L MnCl2•4H2O, 1.6 g / L FeSO4•7H2O, 1.6 g / L CoCl2•5H2O, 1.6 g / L CuSO4•5H2O, 1.11 g / L (NH4)6Mo7O 24 •4H2O, the balance is water; 2. Separation and purification of compound products The fermentation product obtained in 1 above was extracted with an equal volume of extract (89% ethyl acetate (V / V), 10% methanol (V / V) and 1% acetic acid (V / V)), and allowed to stand for 8 hours, stirred every 3 hours, and the extraction was repeated 3 times, and filtered with filter paper to obtain the fermentation extract. The fermentation extract was concentrated under reduced pressure to remove the extract, and a crude extract was obtained as the sample to be separated; First, use Combiflash preparative chromatography for initial separation (chromatographic column: RediSepRf, 120 g C18 column), dissolve the above crude extract with a small amount of methanol, weigh an appropriate amount of diatomaceous earth to mix the sample (the mass ratio of crude extract to diatomaceous earth is 1:2), evaporate to dryness under reduced pressure, load the sample, and the elution conditions are: during 0-40 min, phase B increases linearly from 0% to 100%, and the flow rate is 45 mL / min throughout the process. The collection method is selected as full collection. After the liquid quality test of the tube sampling, the tubes containing the target product are combined and concentrated under reduced pressure, dissolved with methanol, and then purified on HPLC through a semi-preparative column phenomenex Luna 5 µm C18(2), 250 x 10 mm.

[0055] The purification method is as follows: The instrument used is a Thermo U3000 liquid chromatograph, equipped with a phenomenex Luna 5 µmC18(2), 250 x 10 mm column, the liquid column temperature is controlled at 35°C, and the detection wavelengths are set at 220 and 260 nm. The liquid chromatography flow rate is 3 mL / min, the mobile phase A is ultrapure water containing 0.1% formic acid, and the mobile phase B is HPLC-grade acetonitrile containing 0.1% formic acid. Purification is performed using 25% B isocratic elution, and the sample retention time is 20 min.

[0056] The peak of a single compound was collected, and the solvent was removed by vacuum concentration to obtain a monomer compound. Deuterated methanol was used as a solvent, and the compound was structurally analyzed by nuclear magnetic resonance. The compound was identified as sorbic acid ( Figure 4-Figure 8 ).

[0057] 1000 µg of sorbic acid standard (Yuanye Biotechnology, B21124) was accurately weighed and dissolved in 1 mL of chromatographic grade methanol to obtain a sorbic acid solution with a concentration of 1000 µg / mL. The sorbic acid solution was diluted in a serial dilution manner to obtain sorbic acid solutions with concentrations of 500 µg / mL, 250 µg / mL, 125 µg / mL, 62.5 µg / mL, 31.25 µg / mL, 15.625 µg / mL, 7.8125 µg / mL, and 3.9062 µg / mL, respectively. Liquid chromatography was used to prepare a standard curve based on the peak area. The detection method was as follows: The instrument used was a Thermo U3000 liquid chromatograph equipped with a phenomenex Luna 5 µm C18(2), 150 x 3 mm column, the liquid column temperature was controlled at 35°C, and the detection wavelengths were set at 220 and 260 nm. The liquid chromatography flow rate was 3 mL / min, mobile phase A was ultrapure water containing 0.1% formic acid, mobile phase B was HPLC-grade acetonitrile containing 0.1% formic acid, 25% B was used for isocratic elution, and the sample retention time was 20 min.

[0058] Take 1 mg of the crude extract and perform the detection analysis using the above method. Substitute the sample peak area into the standard curve ( Fig. 9 ), calculate the sorbic acid production.

[0059] It was calculated that the sorbic acid production of the recombinant bacteria AN-sa was 142.15 mg / L (calculated based on the volume of the culture medium before solidification).

[0060] The present invention has been described in detail above. It will be apparent to those skilled in the art that the present invention may be implemented in a wide range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the present invention and without the need for unnecessary experimentation. Although the present invention provides specific embodiments, it should be understood that further improvements may be made to the present invention. In short, according to the principles of the present invention, this application intends to include any changes, uses or improvements to the present invention, including changes made by conventional techniques known in the art that depart from the scope disclosed in this application. Applications of some of the basic features may be made within the scope of the following appended claims.

Claims

1. Any of the following substances: A1) Polyketide synthase; A2) biological materials related to the polyketide synthase shown in A1); A3) Hydrolases; A4) biological materials related to the hydrolases shown in A3); A5) A combination of A1) and A3); A6) A combination of A2) and A4); The polyketide synthase is any one of the following: B1) comprising the protein shown in SEQ ID NO: 3; B2) a protein having 95% or more identity with SEQ ID NO: 3 and having the same biological function; The hydrolase is any one of the following: B3) comprising the protein shown in SEQ ID NO: 4; B4) A protein that has 95% or more identity with SEQ ID NO: 4 and has the same biological function.

2. The substance according to claim 1, characterized in that: The biological material related to the polyketide synthase shown in A1) is any one of the following: C1) a nucleic acid molecule encoding the polyketide synthase according to claim 1; C2) an expression cassette containing the nucleic acid molecule described in C1); C3) a recombinant vector containing the nucleic acid molecule described in C1); C4) a recombinant vector containing the expression cassette described in C2); C5) a recombinant microorganism containing the nucleic acid molecule described in C1); C6) a recombinant microorganism containing the expression cassette described in C2); C7) a recombinant microorganism containing the recombinant vector described in C3); C8) a recombinant microorganism containing the recombinant vector described in C4); Or, the biological material related to the hydrolase shown in A3) is any one of the following: D1) a nucleic acid molecule encoding the hydrolase according to claim 1; D2) an expression cassette containing the nucleic acid molecule described in D1); D3) a recombinant vector containing the nucleic acid molecule described in D1); D4) a recombinant vector containing the expression cassette described in D2); D5) a recombinant microorganism containing the nucleic acid molecule described in D1); D6) a recombinant microorganism containing the expression cassette described in D2); D7) a recombinant microorganism containing the recombinant vector described in D3); D8) A recombinant microorganism containing the recombinant vector described in D4).

3. A recombinant microorganism comprising a gene encoding the polyketide synthase and a gene encoding the hydrolase according to claim 1 or 2, and expressing the polyketide synthase and the hydrolase.

4. The recombinant microorganism according to claim 3, characterized in that: The recombinant microorganism is a fungus or a bacterium; And / or, the fungus is Aspergillus nidulans.

5. A method for constructing the recombinant microorganism according to claim 3 or 4, comprising the following steps: introducing the coding gene of the polyketide synthase and the coding gene of the hydrolase in claim 1 or 2 into a host microorganism to obtain a recombinant microorganism.

6. The method according to claim 5, characterized in that: The host microorganism is a fungus or a bacterium; And / or, the fungus is Aspergillus nidulans.

7. A recombinant microorganism prepared by the method of claim 5 or 6.

8. Use of the substance according to claim 1 or 2 in any of the following: E1) preparing a recombinant microorganism for synthesizing sorbic acid; E2) Synthesize sorbic acid.

9. Use of the recombinant microorganism according to claim 3, 4 or 7 in the synthesis of sorbic acid.

10. A method for synthesizing sorbic acid, comprising the following steps: fermenting the recombinant microorganism according to claim 3, 4 or 7 to obtain sorbic acid.

Citation Information

Cited By

  • Sorbic acid synthetic gene cluster and synthetic method

    WO2026031408A1